MannKind

MannKind And Afrezza's NDA Evaluation: What Is The Real Justification For The Advisory Committee?
Seeking Alpha
Fri, 03/28/14 - 08:21 am
MannKind
diabetes
Afrezza
FDA
advisory panels
Does Mannkind Offer a Good Risk to Reward Ratio?
Motley Fool
Sat, 03/22/14 - 11:28 am
MannKind
3 Biotechs With Major Catalysts Incoming
Motley Fool
Wed, 03/19/14 - 11:22 am
dalbavancin
Durata Therapeutics
MannKind
Afrezza
Cologuard
EXACT Sciences
MLV Sees A Good Chance Of FDA Approval For MannKind's Afrezza And 60% Upside
Seeking Alpha
Tue, 03/18/14 - 12:14 pm
FDA
MannKind
Afrezza
diabetes
MannKind: The Gambler's Creed - Let It Ride
Seeking Alpha
Fri, 03/14/14 - 10:54 am
MannKind
Afrezza
diabetes
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Motley Fool
Fri, 03/14/14 - 08:39 am
biotech
Sarepta Therapeutics
OncoMed
Vivus
MannKind
Myriad Genetics
Biotech Stock Mailbag Extra: MannKind's Afrezza Panel Setup
TheStreet.com
Thu, 03/6/14 - 10:28 am
advisory panels
FDA
Afrezza
diabetes
MannKind
inhaled insulin
5 Questions for MannKind
Motley Fool
Thu, 02/20/14 - 08:21 am
MannKind
Afrezza
diabetes
The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind
Motley Fool
Wed, 02/19/14 - 08:44 am
Myriad Genetics
Questcor
Ziopharm
Sarepta Therapeutics
MannKind
MannKind Corporation's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Seeking Alpha
Wed, 02/19/14 - 08:37 am
MannKind
earnings
Is There Investment Upside In The Future Of Treating Diabetes?
Seeking Alpha
Mon, 02/10/14 - 08:43 am
diabetes
MannKind
Merck
Novo Nordisk
NeoStem
Regeneron
MannKind Catalysts: Insights About Diabetes Care Metrics And Long-Term Complications
Seeking Alpha
Thu, 01/23/14 - 08:19 am
diabetes
MannKind
Afrezza
MannKind's Day Of Reckoning Is Getting Very Close
Seeking Alpha
Mon, 01/13/14 - 10:54 am
MannKind
diabetes
Afrezza
2014 Biotechnology Catalysts
Seeking Alpha
Fri, 01/10/14 - 08:14 am
Chelsea Therapeutics
Durect Corporation
EXACT Sciences
Vanda
Pozen
Progenics
MannKind
FDA
MannKind Corporation: One Large Step For Shareholders, One Gigantic Step For Diabetics
Seeking Alpha
Mon, 01/6/14 - 09:43 am
MannKind
diabetes
Afrezza
More Catalysts For MannKind
Seeking Alpha
Fri, 12/6/13 - 11:12 am
MannKind
Afrezza
diabetes
insulin
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
MannKind: A Breakout Biotechnology Bet
Seeking Alpha
Tue, 11/26/13 - 08:49 am
MannKind
Afrezza
diabetes
Boom Or Bubble? Insiders Like The Look Of These 3 Biotech Stocks
The Street
Sat, 11/9/13 - 12:25 pm
BioSpecifics Technologies
MannKind
Acadia
MannKind takes bigger 3Q loss as costs increase
Yahoo/AP
Mon, 11/4/13 - 03:15 pm
MannKind
earnings

Pages